MetLife Inc., US59156R1086

MetLife stock trades at EUR 84.12 minus 0.08 percent

Published on 09/29/2026 at 12:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife stock was quoted at EUR 84.12 on September 29, 2026, minus 0.08 percent versus EUR 84.19. Q2 adjusted EPS rose 20.00 percent to USD 2.43.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund
Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife stock (ISIN US59156R1086) was trading at EUR 84.12 at Lang & Schwarz on September 29, 2026 at 12:38 p.m. CEST, minus 0.08 percent versus the prior close of EUR 84.19. The company disclosed a preliminary Q3 variable investment income estimate that gives investors a fresh measure of portfolio performance.

Q3 estimate reaches USD 600 million

According to StockTitan on September 24, 2026, MetLife estimated at least USD 600.00 million in pre-tax variable investment income for the quarter ending September 30, 2026. The estimate is preliminary and unaudited, so the figure is a forward-looking indicator rather than a completed quarterly result.

The estimate matters because investment income is a material earnings driver for an insurer with a large investment portfolio. MetLife's Q2 balance sheet carried USD 759.4 billion in total assets as of June 30, 2026, while operating cash flow reached USD 2.2 billion in the quarter.

Adjusted EPS rose 20 percent

MetLife's Q2 2026 results provide the operating comparison. StockTitan reported on August 5, 2026 that adjusted earnings increased 15.00 percent to USD 1.6 billion and adjusted EPS rose 20.00 percent to USD 2.43.

GAAP net income attributable to common shareholders was USD 705.0 million in Q2 2026, compared with USD 1.14 billion in Q1 2026. The difference shows why the Q3 investment-income estimate is important: quarterly earnings can vary materially with investment results even when the underlying insurance franchises remain diversified.

Ratings and valuation set the counterpoint

MarketScreener reported on September 15, 2026 that Fitch affirmed MetLife's ratings and kept the outlook stable. Fitch cited strong diversification, while also identifying commercial mortgage exposure as a risk factor, with mortgage loans representing 17.00 percent of investments as of the first half of 2026.

MarketBeat reported on September 27, 2026 that Wall Street Zen upgraded MetLife from hold to buy and that the average analyst target was USD 104.31. On the NYSE, MET was last at USD 95.82 on September 28, 2026 at 4:00 p.m. ET, with a 52-week range of USD 67.33 to USD 100.93 and market capitalization of USD 61.7 billion.

MetLife stock stays near USD 100

MetLife stock was trading at EUR 84.12 at Lang & Schwarz on September 29, 2026 at 12:38 p.m. CEST, minus 0.08 percent versus the Lang & Schwarz prior close of EUR 84.19. The modest daily move leaves the Q3 investment-income estimate and the upcoming reported result as the clearest quantified checkpoints for the shares.

MetLife stock facts

  • Company: MetLife, Inc.
  • ISIN: US59156R1086
  • Ticker: MET
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of September 29, 2026, 12:38 p.m. CEST): EUR 84.12
  • Change versus prior close: minus 0.08 percent
  • Prior close Lang & Schwarz (September 28, 2026): EUR 84.19
  • Market capitalization: USD 61.7 billion (as of September 28, 2026)
  • 52-week range: USD 67.33-100.93 (as of September 28, 2026)
  • Sector / Industry: Financial Services / Insurance - Life

More news and analyses on MetLife stock

Disclaimer...

en | US59156R1086 | METLIFE INC. | boerse | 70197485 | bgmi